Marc Duey - 14 Oct 2024 Form 4 Insider Report for Aprea Therapeutics, Inc. (APRE)

Role
Director
Signature
/s/ John P. Hamill, as Attorney-in-Fact
Issuer symbol
APRE
Transactions as of
14 Oct 2024
Transactions value $
$490
Form type
4
Filing time
16 Oct 2024, 08:30:47 UTC
Previous filing
21 Jun 2024
Next filing
17 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APRE Common Stock Purchase $490 +190 +0.09% $2.58 210,113 14 Oct 2024 Direct
holding APRE Common Stock 602 14 Oct 2024 By Spouse F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, or for any other purpose.